News | April 01, 2026
Merck completes acquisition of JSR Life Sciences’ chromatography business
Broadens downstream purification portfolio with next-generation Protein A chromatography for scalable manufacturing
Broadens downstream purification portfolio with next-generation Protein A chromatography for scalable manufacturing
The showcase, running March 27–31, puts a spotlight on everything from fine lines to daily sun protection
The inspection is now closed, and no regulatory action has been recommended
Vapendavir is an oral, potent, broad-spectrum antiviral active against rhinoviruses and related respiratory enteroviruses
KeyCi’s dermatologically tested lineup emphasizes clean formulations—vegan, cruelty-free, alcohol-free, and paraben-free—while being backed by pharmaceutical-grade research and FDA approval
RSM01, a preventive treatment targeting respiratory syncytial virus (RSV), was licensed earlier this month from the Gates Medical Research Institute
Huwel’s diagnostic solutions leverage open RT-PCR system
The funding will be spread over four years, with BXLS also eligible for regulatory and commercial milestones, plus royalties on worldwide sales
The deal was executed via a merger of Novartis’ wholly owned subsidiary, Ajax Acquisition Sub, Inc., into Avidity
Under the deal, Quiver will receive an undisclosed advance payment and research support
Subscribe To Our Newsletter & Stay Updated
